TARRYTOWN, N.Y., Aug. 22 /PRNewswire-FirstCall/ -- Emisphere Technologies, Inc. (Nasdaq: EMIS) today announced that Paul Lubetkin has been appointed to the position of Vice President and General Counsel, effective September 4, 2007. Mr. Lubetkin will be responsible for the overall planning, management and execution of the legal function, including global intellectual property, transactional legal advice, securities and funding, and commercial transactions. Mr. Lubetkin will report directly to Michael V. Novinski, President and Chief Executive Officer. Emisphere Technologies, Inc. is a biopharmaceutical company that focuses on a unique and improved delivery of therapeutic molecules and pharmaceutical compounds using its eligen(R) technology.
"Paul Lubetkin's understanding of business and legal issues, coupled with his deep knowledge of pharmaceutical law, make him an ideal fit for Emisphere," said Michael V. Novinski, President and Chief Executive Officer of Emisphere Technologies, Inc. "Mr. Lubetkin also brings a real expertise in Regulatory, SEC and Corporate Governance aligned with strong management capabilities. We are very excited to have him bring this wealth of experience to Emisphere."
Mr. Lubetkin is the previous Vice President and General Counsel of
Aptuit, Inc., a private global contract research organization providing
services to the pharmaceutical and biotechnology industries. He was
previously Senior Vice President, General Counsel and Secretary of Odyssey
Pharmaceuticals, Inc., a specialty pharmaceuticals company, where he
managed litigation, negotiated and supervised material transactions, and
provided a wide range of corporate and compliance advice. He is the former
Senior Vice President an
|SOURCE Emisphere Technologies, Inc.|
Copyright©2007 PR Newswire.
All rights reserved